This protocol is judged by an institutional review board, an unbiased group that critiques any clinical trials involving humans. If a study entails a Routine I drug, as soon as the board approves the protocol as moral, the scientists really need to apply for an investigational new drug (IND) selection through the FDA.This information includes a lis